Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.33

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (3643)	6/13/2001 7:57:45 PM
From: Miljenko Zuanic	Read Replies (1) of 52153

<<"BEZ TRECE NEMA SRECE"!>> Ova treca ne izgleda bas sretna! Or, in plain English: We have few M&A, but it is far, far from what we need to consolidate bio-business, or what I think we need. While BMS buying DuPont pharma unit is overall step forward, bios still are going for sale or merge after they dry-up. And, they all will be successful,... until proved opposite! Miljenko PS: Did anyCEO learned anything from LKST case?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next